Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning
{{output}}
Purpose of review: Factor XI (FXI) and its activated form, factor XIa (FXIa), have emerged as a leading novel anticoagulant target of the past decade. This review summarizes mechanistic and clinical data from 2023 through 2026 an... ...
